1Chou HH,Wang KL,Chen CA,et al.Pegylated liposomal doxorubicin(Lipo-Dox)for Platinum-resistant or refractory epithelial ovarian carcinoma:a Taiwan Residents gynecologic oncology group study with long term follow-up[].Gynecologic Oncology.2006
2Petru E,Angleitner-Boubenizek L,Reinthaller A,et al.Combined PEG li-posomal doxorubicin and gemcitabine are active and have acceptable toxicity in patients with platinum refractory and resistant ovarian cancerafter previous platinum-taxane therapy:A phaseⅡAusrtian AGO study[].Gynecologic Oncology.2006
3Delaloge S,Laadem A,Taamma A.Pilot study of the paclitaxel,oxaliplatin,and cisplatin combination in patients with advanced/recurrent ovarian cancer[].American Journal of Clinical Oncology.2000
4Markman M,Blessing J,Rubin SC,et al.PhaseⅡtrial of weekly paclitax-el(80mg/m2)in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers:a Gynecologic Oncolohy Group study[].Gynecologic Oncology.2006
5Tait DL,Obermiller PS,Hatmaker AR,et al.Ovarian cancer BRCA1gene therapy:PhaseⅠandⅡtrial differences in immune response and vector stability[].Clinical Cancer Research.1999
6David Spriggs.Optimal sequencing in the treatment of recurrent ovarian cancer[].Gynecologic Oncology.2003
7Wen SF,Mahavni V,Quijano E,et al.Assessment of p53 gene transfer and biological activities in a clinical study of adenovirus-p53 gene therapy for recurrent ovarian cancer[].Cancer Gene Therapy.2003
8Hasenburg A,Fischer DC,Tong XW,et al.Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes simplex thymidine kinase gene therapy of ovarian cancer[].International Journal of Gynecological Cancer.2002
9Bciman ML.Future directions in the surgical management of ovarian cancer[].Gynecologic Oncology.2003
6Sundstrom s,Bremnes RM,Kaasa S,et al.Second-line chemotherapy in recurrent small cell lung cancer:results from a crossover schedule after primary treatment mt h cisplatinand etoposide(EP-regimen)or cyclophosphamide,epirubicin and vlncristin(CEV-regimen)[J].Lung Cancer,2005,48(2):251-261.
7Pfisterer J,Plante M,Vergote I,et al.Gemcitabine/carbop latin(GC)vs carboplatinin(C)platinum sensitive recurrent ovariancancer(OVCA):results of a Gynecologic Cancer Intergroup randomized phase Ⅲ trial of the AGO OVAR,the NCIC CTG and the EORTC GCG[J].Proc Am Soc Clin Oncol,2004,449:5005.
8Seliger G,Mueller LP,Büchele T,et al.Salvage chemotheray with docetaxel,oxaliplatin and gemcitabine in platinum-pretreated advanced epithelial ovarian cancer:P reliminary results of a phase Ⅱ study(Abstact)[J].Proc Am Soc Clin Oncol,2002,21:864.
